Microport Cardioflow Medtech Corp 2160-HK:Hong Kong Stock Exchange

*Data is delayed | HKD
Last | 06/24/22 CTT
3.43quote price arrow up+0.65 (+23.38%)
Volume
39,047,192
52 week range
2.05 - 16.80
Loading...
  • Open2.76
  • Day High3.48
  • Day Low2.76
  • Prev Close2.78
  • 52 Week High16.80
  • 52 Week High Date06/29/21
  • 52 Week Low2.05
  • 52 Week Low Date03/15/22

Key Stats

  • Market Cap860.39M
  • Shares Out2,403.56M
  • 10 Day Average Volume8.4M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-11.37

KEY STATS

  • Open2.76
  • Day High3.48
  • Day Low2.76
  • Prev Close2.78
  • 52 Week High16.80
  • 52 Week High Date06/29/21
  • 52 Week Low2.05
  • 52 Week Low Date03/15/22
  • Market Cap860.39M
  • Shares Out2,403.56M
  • 10 Day Average Volume8.4M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-11.37

RATIOS/PROFITABILITY

  • EPS (TTM)-0.10
  • P/E (TTM)-35.73
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Microport Cardioflow Medtech Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Microport Cardioflow Medtech Corp is a China-based investment holding company mainly engaged in the medical device industry. The Company is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The Company's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The Company mainly conducts business...
Qiyi Luo
Non-Executive Chairman of the Board
Guoming Chen
President, Executive Director
Luying Yan
Vice President, Executive Director
Address
Shanghai, SHA
China